Harte-Hanks (NYSE: HHS) reported Q1 EPS of ($0.12), $0.05 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $94.89 million versus the consensus estimate of $94 million.

For earnings history and earnings-related data on Harte-Hanks (HHS) click here.